Stereotactic Body Radiotherapy Aids Spinal Metastasis Pain
MONDAY, June 21, 2021 -- Stereotactic body radiotherapy is superior to conventional external beam radiotherapy for improving the complete response rate for pain associated with spinal metastasis, according to a study published online June 11 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2021 Category: Pharmaceuticals Source Type: news

Dartmouth-invented technology allows doctors to see beam field during radiation treatment
(Dartmouth-Hitchcock Medical Center) With the use of the BeamSite Cherenkov imaging camera system invented by DoseOptics, LLC., radiation oncologists at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center can capture real-time external beam delivery images during cancer patients' standard radiation therapy sessions. These images are used to verify that the beam is targeting the exact area intended, and make necessary adjustments to prevent unintentional exposure to patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2021 Category: Cancer & Oncology Source Type: news

Outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer
(NRG Oncology) Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) prostate brachytherapy (BT) following local recurrence (LR) after external beam radiotherapy (EBRT) for patients with low-to-intermediate risk prostate cancer reported late Grade 3 gastrointestinal and genitourinary adverse events (AEs) occurring in 14% of trial participants. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 28, 2020 Category: Cancer & Oncology Source Type: news

One-Off Blast of RT, Rather Than Weeks, for Early Breast Cancer One-Off Blast of RT, Rather Than Weeks, for Early Breast Cancer
New long-term results with targeted intraoperative radiotherapy (TARGIT) show similar efficacy to whole breast external beam radiotherapy, which is still the standard of care.Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - August 25, 2020 Category: OBGYN Tags: Hematology-Oncology News Source Type: news

Targeted Intraoperative RT Is Effective Alternative to EBRT
FRIDAY, Aug. 21, 2020 -- Single-dose targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy is an effective alternative to external beam radiotherapy (EBRT), according to a study published online Aug. 19 in The BMJ. Jayant S. Vaidya,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2020 Category: Pharmaceuticals Source Type: news

ASTRO issues first clinical guideline on radiation therapy for cervical cancer
(American Society for Radiation Oncology) A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer. The guideline--ASTRO's first for cervical cancer--outlines indications and best practices for external beam radiation therapy and brachytherapy in the postoperative and definitive settings. Recommendations also address other treatments including chemotherapy and surgery when used in combination with radiation. The guideline is published online in Practical Radiation Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 10, 2020 Category: Cancer & Oncology Source Type: news

Targeted Intraoperative Radiotherapy vs External Beam Radiotherapy in Patients with Breast Cancer
This study examined delayed targeted intraoperative radiotherapy vs external beam radiotherapy to determine how it impacted patients with breast cancer, finding no statically significant decrease in mastectomy-free survival, distant-disease survival or overall survival. (Source: CancerNetwork)
Source: CancerNetwork - April 16, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

Long-term study finds faster breast cancer radiation treatment as effective as long course
(McMaster University) Approximately half of the patients were randomly assigned whole breast radiation, delivered once per day over 3 to 5 weeks. The other half received external beam APBI which was given twice a day over 5 to 8 days. The study was long-term, with a median followup of 8.6 years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2019 Category: Cancer & Oncology Source Type: news

AngioDynamics Sets Sights on Prostate Cancer with New IDE
FDA has given approval for AngioDynamics to undergo a pilot study of the NanoKnife for the ablation of prostate cancer tissue in low-risk patients. The IDE comes on the heels of the Latham, NY-based company making significant strides in its mission to obtain an indication for the treatment of pancreatic cancer. “NanoKnife has been in the market for a general soft tissue claim for about eight or nine years,” Brent Boucher, AngioDynamics, Senior VP and General Manager of Oncology, told MD+DI. “On April 1 we received approval to pursue a pancreas indication for stage three...
Source: MDDI - May 28, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Brachytherapy Boost Ups Survival in Locally Advanced Cervical Cancer
MONDAY, March 25, 2019 -- The current standard of care (SOC) for advanced cervical cancer -- external beam radiation therapy (EBRT) and chemotherapy in combination with brachytherapy -- provides significantly higher overall survival over... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 25, 2019 Category: Pharmaceuticals Source Type: news

Shorter course of radiation therapy effective in treating men with prostate cancer
A new UCLA-led study shows that men with low- or intermediate-risk prostate cancer can safely undergo higher doses of radiation over a significantly shorter period of time and still have the same, successful outcomes as from a much longer course of treatment.This type of radiation, known as stereotactic body radiotherapy, is a form of external beam radiation therapy and reduces the duration of treatment from 45 days to four to five days. The approach has been in use since 2000, but has not yet been widely adopted because of concerns over how safe and effective this approach would be in the long term.“Most men with low- o...
Source: UCLA Newsroom: Health Sciences - February 8, 2019 Category: Universities & Medical Training Source Type: news

University of Maryland doctors treat first breast cancer patients with GammaPod radiotherapy
(University of Maryland Medical Center) Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are now treating patients with the GammaPod ™ , a new FDA-cleared radiation therapy for early-stage breast cancer. The UMGCCC is the first site to treat patients with this first-of-its-kind system, which was invented by University of Maryland School of Medicine (UMSOM) scientists and physicians. This is the only external-beam radiation delivery system specifically designed to treat breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Cells to Society: $3.4 Million in Grants / New FAANs / Research News
This study explores survivors’ perspectives on secondary prevention of campus sexual assault and effective strategies for intervention.     Read more   Mental Health ...
Source: Johns Hopkins University and Health Systems Archive - November 9, 2018 Category: Nursing Source Type: news

External Beam Radiotherapy for Prostate Cancer Increases Bladder-Cancer Risk External Beam Radiotherapy for Prostate Cancer Increases Bladder-Cancer Risk
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 5, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Do Some Prostate Cancer Therapies Raise Patients ’ Risks for Bladder Cancer?
Treatment for prostate cancer with external beam radiotherapy was found to be associated with an increased risk for development of bladder cancer when compared with radical prostatectomy. (Source: CancerNetwork)
Source: CancerNetwork - October 18, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news